Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost.
Craig RodgersKrista J SiefriedAlison RitterVendula BelackovaCarla TreloarMarianne JaunceyNadine EzardDarren RobertsMaureen SteeleWillem van den BrinkJohn StrangEugenia Oviedo-JoekesNicholas LintzerisAdrian John DunlopJames BellPublished in: BMJ open (2024)
ACTRN12621001729819.